Pharmaron is a leading service provider in the life sciences industry, offering a wide range of research, development, and manufacturing services for drug discovery and clinical development processes. Established in 2004, Pharmaron boasts expansive capabilities across multiple therapeutic modalities with a workforce of over 20,000 employees. Operating in China, the U.S., and the U.K., the company has a strong track record of delivering R&D solutions to partners globally. Its services span synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, and more. With a focus on CRO and CDMO, Pharmaron's offerings include library synthesis, bioorganic chemistry, in vitro and in vivo biology, regulatory affairs, and drug product manufacturing. The company's website, www.pharmaron.com, provides additional details about its extensive service portfolio.
There is no investment information
No recent news or press coverage available for Pharmaron.